Optimizing Dolutegravir Initiation in Neonates Using Population Pharmacokinetic Modeling and Simulation
Conclusions:
Newborn DTG dosing requirements during the first few days of life depend on maternal DTG dosing history before delivery. These results may help the design of future clinical studies of DTG in the neonatal population.
Source: JAIDS Journal of Acquired Immune Deficiency Syndromes - Category: Infectious Diseases Tags: Clinical Science Source Type: research
More News: Clinical Trials | HIV AIDS | Infectious Diseases | Pediatrics | Perinatology & Neonatology | Pregnancy | Science | Study | Women